Literature DB >> 10208703

Health screening in older women.

C P Mouton1, D V Espino.   

Abstract

Health screening is an important aspect of health promotion and disease prevention in women over 65 years of age. Screening efforts should address conditions that cause significant morbidity and mortality in this age group. In addition to screening for cardiovascular disease, cerebrovascular disease and cancer, primary care physicians should identify risk factors unique to an aging population. These factors include hearing and vision loss, dysmobility or functional impairment, osteoporosis, cognitive and affective disorders, urinary incontinence and domestic violence. Although screening for many conditions cannot be proved to merit an "A" recommendation (indicating conclusive proof of benefit), special attention to these factors can decrease morbidity and improve quality of life in aging women.

Entities:  

Mesh:

Year:  1999        PMID: 10208703

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  3 in total

1.  Correlates of use of antifracture therapy in older women with low bone mineral density.

Authors:  Kathryn M Ryder; Ronald I Shorr; Frances A Tylavsky; Andrew J Bush; Douglas C Bauer; Eleanor M Simonsick; Elsa S Strotmeyer; Tamara B Harris
Journal:  J Gen Intern Med       Date:  2006-06       Impact factor: 5.128

2.  36-Item Short Form Survey (SF-36) Versus Gait Speed As Predictor of Preclinical Mobility Disability in Older Women: The Women's Health Initiative.

Authors:  Deepika R Laddu; Betsy C Wertheim; David O Garcia; Nancy F Woods; Michael J LaMonte; Bertha Chen; Hoda Anton-Culver; Oleg Zaslavsky; Jane A Cauley; Rowan Chlebowski; JoAnn E Manson; Cynthia A Thomson; Marcia L Stefanick
Journal:  J Am Geriatr Soc       Date:  2018-02-10       Impact factor: 5.562

3.  Three year health outcomes among older women at risk of elder abuse: women's health Australia.

Authors:  Margot J Schofield; Gita D Mishra
Journal:  Qual Life Res       Date:  2004-08       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.